Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you stop weight loss injections such as tirzepatide (Mounjaro) or semaglutide (Wegovy), appetite typically returns and weight often begins to come back — research suggests many people regain a significant portion of lost weight within a year of stopping. That is not a failure of willpower; it reflects how these medicines work and what happens when you withdraw them. They are prescription-only medicines, and any decision about stopping, pausing or continuing should be made with a prescriber who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been on weight loss injections for several months, things are going well, and then (for whatever reason) you take your last pen, put it in a sharps container, and that's it. Within a few days, the medicine's concentration in your blood drops substantially, and by the end of the first week or two, most of the appetite-regulating effect has faded.
Both tirzepatide and semaglutide work by activating gut-hormone receptors that slow gastric emptying and reduce appetite signals reaching the brain. Once you stop, those receptors return to their baseline state. Hunger (real, biological hunger) comes back. Portion sizes that felt comfortable on treatment can suddenly feel insufficient. This is not psychological; it is physiological, and the NHS patient information on tirzepatide is clear that the medicine works as long as you take it, not indefinitely after you stop.
Most people also notice that the slight nausea or reduced interest in fatty foods, which had been quietly keeping portions in check, disappears. Food becomes more appealing again. If you're curious about what happens when you stop weight loss injections, recognising these changes early, rather than being surprised by them, makes it much easier to respond thoughtfully rather than reactively.
The honest answer is: quite a lot, for many people, and faster than most expect. The STEP 1 trial extension, published in the New England Journal of Medicine, followed participants who stopped semaglutide after 68 weeks. Within a year of stopping, two-thirds of the weight lost had been regained on average, and the metabolic improvements (blood pressure, blood sugar, cholesterol) also largely reversed.
Tirzepatide data points in the same direction. This is why weight loss injections are increasingly described as long-term treatments for a chronic condition rather than short-term courses. Obesity involves lasting changes to the hormones that regulate energy balance. The medicine compensates for those changes while it is present; removing it removes that compensation.
There are people who do better than average after stopping, particularly those who have made durable changes to what and how they eat, and who have kept up regular activity. Reading up on what to eat when taking weight loss injections matters for exactly this reason: the habits you build during treatment are the ones that do the most work afterwards.
Stopping is not dangerous in the way that abruptly withdrawing some medicines is. There is no severe withdrawal syndrome. But there is a right way to approach it. Before stopping, it is worth talking through your reasons. Common ones include cost, side effects, reaching a target weight, or a planned surgical procedure, your anaesthetist needs to know you are on a GLP-1 medicine before any operation, for safety reasons around gastric emptying and aspiration risk.
A prescriber can help you think about timing. If cost is the driver, it is worth exploring what a structured private prescription actually covers, because some people stop for financial reasons without realising the full picture. If you've hit your goal weight and feel ready, your prescriber might suggest a gradual dose reduction rather than an abrupt stop, to give your appetite system a gentler transition.
It's also worth thinking carefully about what happens if you stop weight loss injections before your last injection, so the weeks leading up to it are spent being deliberate about routines, the kind you can sustain on an ordinary Tuesday without thinking hard about it.
Some people stop, regain weight, and decide to restart. That is clinically reasonable. Whether restarting is right for you depends on your health picture at that point, and a prescriber needs to review your current weight, any changes to your health, and which dose is appropriate to restart at. You would not simply pick up where you left off, restarting typically means returning to the lowest dose and titrating again, for the same tolerability reasons as the first time.
At nume, every repeat order (including a restart after a break) gets a fresh clinical review before anything is dispensed. A real prescriber looks at your updated details; there is no automated restart. If you have questions about the process or want to talk through whether continuing, pausing or stopping makes most sense for you, our clinical team is available seven days a week. You can also browse our FAQs for answers to common questions about ongoing treatment. For broader context on weight management approaches available in the UK, that page is a reasonable starting point. When you're ready to talk to a prescriber, starting a free consultation is the first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.